Edwards Lifesciences (EW)
(Delayed Data from NYSE)
$85.25 USD
+0.19 (0.22%)
Updated May 3, 2024 04:00 PM ET
After-Market: $85.27 +0.02 (0.02%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 7/24/24 |
---|---|
Current Quarter | 0.70 |
EPS Last Quarter | 0.66 |
Last EPS Surprise | 3.13% |
ABR | 2.16 |
Earnings ESP
|
0.25% |
---|---|
Current Year | 2.77 |
Next Year | 3.11 |
EPS (TTM) | 2.55 |
P/E (F1) | 30.79 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.66B | 1.62B | 6.56B | 7.18B |
# of Estimates | 11 | 12 | 11 | 12 |
High Estimate | 1.67B | 1.65B | 6.60B | 7.30B |
Low Estimate | 1.64B | 1.60B | 6.52B | 7.09B |
Year ago Sales | 1.53B | 1.48B | 6.00B | 6.56B |
Year over Year Growth Est. | 8.20% | 9.56% | 9.30% | 9.45% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.70 | 0.69 | 2.77 | 3.11 |
# of Estimates | 13 | 11 | 13 | 13 |
Most Recent Consensus | 0.69 | 0.70 | 2.78 | 3.11 |
High Estimate | 0.71 | 0.71 | 2.80 | 3.18 |
Low Estimate | 0.68 | 0.68 | 2.75 | 3.04 |
Year ago EPS | 0.66 | 0.59 | 2.51 | 2.77 |
Year over Year Growth Est. | 6.06% | 16.95% | 10.36% | 12.34% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 2 | 6 | 7 |
Up Last 60 Days | 1 | 3 | 8 | 7 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 6 | 3 | 0 | 1 |
Down Last 60 Days | 4 | 3 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.70 | 0.69 | 2.77 | 3.11 |
7 Days Ago | 0.70 | 0.69 | 2.77 | 3.11 |
30 Days Ago | 0.70 | 0.69 | 2.76 | 3.10 |
60 Days Ago | 0.70 | 0.69 | 2.76 | 3.09 |
90 Days Ago | 0.69 | 0.68 | 2.74 | 3.06 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.70 | 0.69 | 2.77 | 3.10 |
Zacks Consensus Estimate | 0.70 | 0.69 | 2.77 | 3.11 |
Earnings ESP | 0.25% | 0.47% | -0.04% | -0.31% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.66 | 0.64 | 0.59 | 0.66 | NA |
Estimate | 0.64 | 0.64 | 0.59 | 0.65 | NA |
Difference | 0.02 | 0.00 | 0.00 | 0.01 | 0.01 |
Surprise | 3.13% | 0.00% | 0.00% | 1.54% | 1.17% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more